Lupin Gets Approval from US FDA for Midostaurin Capsules
Lupin has secured approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Midostaurin Capsules.
Aggressive Systemic Mastocytosis | 18/05/2024 | By Aishwarya | 202
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy